Vibha Mohindra, MD
Pulmonary Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 24
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
24 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mohindra’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
24 of 24 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54233 · Current
Licensed to practise in California · since 1995 · expires 2026-12-31 · University of Delhi, Maulana Azad Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$75,064
Medicare paid this office $75,064 for 368 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 79 | $39,109 | $184 |
| Return visit (30+ min) | 101 | $10,286 | $82 |
| Short return visit (20+ min) | 107 | $6,627 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,761 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,498 | $147 |
See all 11 services
| Critical care, first 30-74 minutes | 79 | $39,109 | $184 |
| Return visit (30+ min) | 101 | $10,286 | $82 |
| Short return visit (20+ min) | 107 | $6,627 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,761 | $70 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,498 | $147 |
| Short return visit | 56 | $1,911 | $29 |
| New patient visit (45+ min) | 13 | $1,445 | $111 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 13 | $1,012 | $72 |
| New patient visit (15+ min) | 18 | $684 | $38 |
| New patient visit (30+ min) | 12 | $623 | $52 |
| Insertion of artery tube for blood sampling or infusion through skin | 15 | $567 | $38 |
Who their Medicare patients are
368 Original Medicare patients in 2024. Average age 71 · Under 65 19% · 85 and older 11% · Women 46% · Also on Medicaid 82% · Health risk score 2.52. Above the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · Diabetes 52% · Heart failure 34% · COPD 32% · Chronic kidney disease 31% · Coronary heart disease 29% · Atrial fibrillation 27% · Depression 27% · Dementia 14% · Stroke 14% · Cancer 13%.
The office billed $899,439, Medicare allowed $98,603 and paid $75,064; for 755 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 368 | 755 | 71 | 2.52 | $899,439 | $75,064 |
| 2023 | 304 | 560 | 69 | 2.42 | $566,451 | $55,253 |
| 2022 | 342 | 628 | 69 | 1.67 | $623,746 | $66,083 |
| 2021 | 198 | 431 | 70 | 2.58 | $469,805 | $52,295 |
| 2020 | 222 | 494 | 69 | 3.02 | $644,235 | $67,900 |
| 2019 | 579 | 1,100 | 68 | 1.99 | $875,423 | $81,751 |
| 2018 | 288 | 619 | 68 | 2.42 | $708,084 | $65,839 |
| 2017 | 356 | 801 | 69 | 2.19 | $726,768 | $73,926 |
| 2016 | 424 | 834 | 66 | 1.70 | $489,517 | $60,596 |
| 2015 | 388 | 849 | 66 | 1.89 | $473,586 | $69,647 |
| 2014 | 407 | 800 | 66 | 1.50 | $389,854 | $63,282 |
| 2013 | 314 | 610 | 66 | 1.96 | $292,059 | $49,888 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Critical care, first 30-74 minutes | 68 | $28,692 | $197 |
| Return visit (30+ min) | 58 | $5,320 | $79 |
| Short return visit (20+ min) | 92 | $5,273 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $5,144 | $75 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,959 | $164 |
| Short return visit | 27 | $1,046 | $33 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $793 | $50 |
| Test to determine lung volumes using sensors | 12 | $107 | $9 |
| Test to examine how well the lungs exchange gases | 12 | $81 | $7 |
2022: 9 services
| Critical care, first 30-74 minutes | 61 | $33,617 | $226 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $8,207 | $109 |
| Short return visit (20+ min) | 97 | $6,913 | $58 |
| Return visit (30+ min) | 47 | $4,462 | $84 |
| Telephone medical discussion with physician, 11-20 minutes | 63 | $3,632 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,403 | $218 |
| Short return visit | 34 | $1,066 | $30 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $509 | $25 |
| Test to examine how well the lungs exchange gases | 11 | $91 | $8 |
2021: 8 services
| Critical care, first 30-74 minutes | 50 | $26,153 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,184 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $4,856 | $221 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,439 | $74 |
| Return visit (30+ min) | 22 | $2,305 | $92 |
| Short return visit (20+ min) | 23 | $1,523 | $61 |
| Telephone medical discussion with physician, 5-10 minutes | 30 | $1,039 | $32 |
| Test to examine how well the lungs exchange gases | 12 | $92 | $8 |
2020: 8 services
| Critical care, first 30-74 minutes | 68 | $45,124 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 37 | $6,242 | $111 |
| Return visit (30+ min) | 35 | $2,450 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,310 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,232 | $74 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,513 | $76 |
| Telephone medical discussion with physician, 11-20 minutes | 24 | $774 | $32 |
| Short return visit (20+ min) | 12 | $283 | $24 |
2019: 14 services
| Critical care, first 30-74 minutes | 70 | $34,440 | $191 |
| Short return visit (20+ min) | 301 | $16,096 | $38 |
| Return visit (30+ min) | 122 | $8,067 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $7,080 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,801 | $175 |
| New patient visit (45+ min) | 22 | $1,873 | $85 |
| New patient visit (30+ min) | 41 | $1,791 | $44 |
| New patient visit (15+ min) | 34 | $1,295 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,127 | $66 |
| Sleep study including heart rate, breathing, airflow, and effort | 18 | $792 | $44 |
| Short return visit | 11 | $186 | $17 |
| Test to determine lung volumes using sensors | 17 | $113 | $7 |
| Test to measure expiratory airflow and volume | 17 | $93 | $5 |
| Test to examine how well the lungs exchange gases | 17 | $84 | $5 |
2018: 10 services
| Critical care, first 30-74 minutes | 68 | $34,296 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,834 | $92 |
| Return visit (30+ min) | 73 | $4,621 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,898 | $170 |
| Short return visit (20+ min) | 63 | $2,625 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,615 | $65 |
| Sleep study in sleep lab (6 years or older) | 23 | $2,312 | $101 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $1,602 | $107 |
| Critical care, each additional 30 minutes | 11 | $1,275 | $98 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $722 | $56 |
2017: 13 services
| Critical care, first 30-74 minutes | 73 | $37,555 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $9,134 | $65 |
| Return visit (30+ min) | 83 | $6,292 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,603 | $180 |
| Short return visit (20+ min) | 80 | $3,572 | $41 |
| Critical care, each additional 30 minutes | 16 | $2,361 | $98 |
| Sleep study in sleep lab (6 years or older) | 22 | $2,089 | $95 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,485 | $114 |
| Sleep study including heart rate, breathing, airflow, and effort | 15 | $798 | $53 |
| Test to determine lung volumes using sensors | 31 | $266 | $8 |
| Test to measure expiratory airflow and volume | 33 | $205 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 20 | $165 | $8 |
| Test to examine how well the lungs exchange gases | 25 | $152 | $6 |
2016: 11 services
| Critical care, first 30-74 minutes | 49 | $24,021 | $194 |
| Short return visit (20+ min) | 230 | $14,341 | $40 |
| Return visit (30+ min) | 83 | $5,550 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $5,401 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,885 | $170 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 16 | $1,597 | $100 |
| Sleep study including heart rate, breathing, airflow, and effort | 30 | $1,354 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,204 | $93 |
| Test to determine lung volumes using sensors | 17 | $144 | $8 |
| Test to examine how well the lungs exchange gases | 15 | $90 | $6 |
| Test to measure expiratory airflow and volume | 12 | $76 | $6 |
2015: 12 services
| Critical care, first 30-74 minutes | 65 | $35,583 | $189 |
| Short return visit (20+ min) | 201 | $13,725 | $42 |
| Return visit (30+ min) | 74 | $4,978 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 47 | $4,676 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,595 | $173 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,438 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,359 | $91 |
| Critical care, each additional 30 minutes | 11 | $1,150 | $96 |
| Test to determine lung volumes using sensors | 14 | $119 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 13 | $103 | $8 |
| Test to examine how well the lungs exchange gases | 12 | $80 | $7 |
| Test to measure expiratory airflow and volume | 14 | $74 | $5 |
2014: 12 services
| Critical care, first 30-74 minutes | 53 | $30,101 | $194 |
| Short return visit (20+ min) | 228 | $13,491 | $42 |
| Return visit (30+ min) | 68 | $4,140 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 28 | $2,818 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,033 | $92 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 15 | $1,267 | $84 |
| Sleep study in sleep lab (6 years or older) | 11 | $988 | $90 |
| New patient visit (30+ min) | 16 | $923 | $58 |
| Administration of influenza virus vaccine | 11 | $342 | $31 |
| Test to determine lung volumes using sensors | 15 | $166 | $11 |
| Test to measure expiratory airflow and volume | 17 | $129 | $8 |
| Test to examine how well the lungs exchange gases | 14 | $114 | $8 |
2013: 13 services
| Critical care, first 30-74 minutes | 60 | $24,277 | $188 |
| Short return visit (20+ min) | 114 | $4,629 | $38 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,662 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $3,418 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,809 | $176 |
| Return visit (30+ min) | 37 | $2,554 | $62 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 24 | $1,997 | $83 |
| Long return visit (40+ min) | 13 | $959 | $74 |
| Sleep study in sleep lab (6 years or older) | 13 | $865 | $67 |
| Test to determine lung volumes using sensors | 21 | $210 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 19 | $174 | $9 |
| Test to examine how well the lungs exchange gases | 23 | $162 | $7 |
| Test to measure expiratory airflow and volume | 18 | $113 | $6 |
Medicaid work
$36,405 in 2024
Medicaid paid $36,405 for 10,292 billed services this clinician did in 2024, up to 278 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 245 | $11,301 |
| Short return visit (20+ min) | 856 | $7,612 |
| Return visit (30+ min) | 484 | $5,505 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 368 | $4,607 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 313 | $2,966 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 14 | $1,440 |
| Short return visit | 325 | $1,175 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 131 | $943 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 35 | $421 |
| New patient visit (30+ min) | 26 | $231 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 56 | $194 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 39 | $10 |
| 2024 | 10,292 | 23 | 278 | $36,405 |
| 2023 | 1,836 | 18 | 70 | $14,146 |
| 2022 | 1,166 | 10 | 70 | $12,590 |
| 2021 | 456 | 7 | 24 | $16,120 |
| 2020 | 772 | 9 | 115 | $15,421 |
| 2019 | 2,474 | 13 | 134 | $23,313 |
| 2018 | 2,393 | 11 | 148 | $26,709 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 207 | $9,004 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 244 | $1,767 |
| Short return visit (20+ min) | 453 | $1,319 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 97 | $931 |
| Return visit (30+ min) | 103 | $588 |
| Short return visit | 203 | $178 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 31 | $79 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 33 | $77 |
| Diffusing capacity | 32 | $72 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 23 | $61 |
| EVALUATION OF WHEEZING | 14 | $57 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 12 | $14 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 140 | $8,320 |
| Short return visit (20+ min) | 495 | $1,995 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $820 |
| Return visit (30+ min) | 74 | $611 |
| Short return visit | 266 | $551 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 96 | $221 |
| Diffusing capacity | 29 | $41 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 12 | $32 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 12 | $0 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 17 | $0 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 234 | $14,460 |
| Short return visit (20+ min) | 91 | $699 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 21 | $503 |
| Short return visit | 72 | $295 |
| Return visit (30+ min) | 12 | $89 |
| Diffusing capacity | 13 | $40 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 13 | $33 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 153 | $10,072 |
| Short return visit (20+ min) | 318 | $1,632 |
| Return visit (30+ min) | 110 | $1,265 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 55 | $1,060 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 40 | $822 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 51 | $438 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 16 | $57 |
| Diffusing capacity | 16 | $39 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 13 | $36 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 256 | $11,046 |
| Short return visit (20+ min) | 1,267 | $4,644 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 148 | $2,114 |
| Return visit (30+ min) | 393 | $2,012 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 149 | $1,626 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 65 | $1,337 |
| New patient visit (30+ min) | 32 | $247 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 56 | $95 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 12 | $59 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 36 | $50 |
| Diffusing capacity | 34 | $33 |
| EVALUATION OF WHEEZING | 12 | $32 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 285 | $13,156 |
| Short return visit (20+ min) | 1,183 | $4,405 |
| Return visit (30+ min) | 337 | $2,287 |
| New patient visit (30+ min) | 211 | $2,264 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 88 | $1,789 |
| OFF/OP CONSLTJ NEW/EST SF 20 | 158 | $1,690 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 68 | $735 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 21 | $262 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 15 | $48 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 14 | $44 |
| Diffusing capacity | 13 | $29 |
Drugs they prescribed that Part D paid
$397,797
Pharmacies billed $397,797 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 589) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
249 generic and 340 brand-name prescriptions · $397,797 in drug cost · 25 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 16 | $194,524 | $12,158 |
| Nucala | 19 | $66,547 | $3,502 |
| Spiriva Handihaler | 64 | $37,464 | $585 |
| Advair Hfa | 27 | $10,342 | $383 |
| Incruse Ellipta | 31 | $10,252 | $331 |
See all 19 drugs
| Ofev | 16 | $194,524 | $12,158 |
| Nucala | 19 | $66,547 | $3,502 |
| Spiriva Handihaler | 64 | $37,464 | $585 |
| Advair Hfa | 27 | $10,342 | $383 |
| Incruse Ellipta | 31 | $10,252 | $331 |
| Dulera | 25 | $8,481 | $339 |
| Trelegy Ellipta | 14 | $8,320 | $594 |
| Breo Ellipta | 20 | $7,915 | $396 |
| Spiriva Respimat | 12 | $6,044 | $504 |
| Budesonide-Formoterol | 20 | $5,348 | $267 |
| Fluticasone Propionate Hfa | 12 | $3,798 | $316 |
| Albuterol Sulfate Hfa | 55 | $2,094 | $38 |
| Mycophenolate Mofetil | 11 | $558 | $51 |
| Fluticasone Propionate | 34 | $418 | $12 |
| Azelastine | 11 | $177 | $16 |
| Montelukast | 15 | $149 | $10 |
| Pantoprazole | 25 | $119 | $5 |
| Prednisone | 24 | $80 | $3 |
| Gabapentin | 11 | $22 | $2 |
Year by year
| 2024 | 589 | 111 | 0% (0) | 58% | $397,797 |
| 2023 | 610 | 107 | 0% (0) | 55% | $402,333 |
| 2022 | 540 | 91 | 0% (0) | 59% | $300,407 |
| 2021 | 659 | 101 | 0% (0) | 65% | $402,672 |
| 2020 | 743 | 115 | 0% (0) | 75% | $294,624 |
| 2019 | 829 | 143 | None | 72% | $362,805 |
| 2018 | 847 | 143 | None | 70% | $389,136 |
| 2017 | 1,032 | 151 | 0% (0) | 67% | $279,421 |
| 2016 | 849 | 138 | None | 60% | $144,072 |
| 2015 | 647 | 116 | None | 66% | $135,028 |
| 2014 | 500 | 108 | None | 70% | $82,684 |
| 2013 | 478 | 96 | None | 67% | $95,878 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Ofev | 14 | $173,293 | $12,378 |
| Nucala | 12 | $48,350 | $4,029 |
| Ethacrynic Acid | 12 | $27,870 | $2,323 |
| Symbicort | 60 | $23,738 | $396 |
| Spiriva Handihaler | 35 | $23,098 | $660 |
| Advair Diskus | 33 | $18,935 | $574 |
| Incruse Ellipta | 44 | $18,437 | $419 |
| Ambrisentan | 11 | $15,786 | $1,435 |
| Flovent Hfa | 23 | $9,969 | $433 |
| Spiriva Respimat | 17 | $8,875 | $522 |
| Advair Hfa | 12 | $6,918 | $577 |
| Breo Ellipta | 14 | $5,782 | $413 |
| Albuterol Sulfate Hfa | 43 | $1,749 | $41 |
| Fluticasone Propionate | 61 | $1,148 | $19 |
| Ventolin Hfa | 17 | $1,143 | $67 |
| Azithromycin | 18 | $423 | $23 |
| Pantoprazole | 18 | $254 | $14 |
| Montelukast | 19 | $251 | $13 |
| Spironolactone | 13 | $133 | $10 |
| Prednisone | 22 | $63 | $3 |
2022: 15 drugs
| Ofev | 12 | $135,928 | $11,327 |
| Advair Diskus | 41 | $28,657 | $699 |
| Spiriva Handihaler | 41 | $22,512 | $549 |
| Symbicort | 44 | $14,769 | $336 |
| Breo Ellipta | 23 | $8,654 | $376 |
| Incruse Ellipta | 20 | $8,418 | $421 |
| Flovent Hfa | 23 | $7,434 | $323 |
| Albuterol Sulfate Hfa | 45 | $2,052 | $46 |
| Ventolin Hfa | 20 | $1,239 | $62 |
| Fluticasone Propionate | 62 | $803 | $13 |
| Montelukast | 17 | $190 | $11 |
| Prednisone | 28 | $167 | $6 |
| Pantoprazole | 18 | $128 | $7 |
| Spironolactone | 11 | $111 | $10 |
| Famotidine | 13 | $55 | $4 |
2021: 18 drugs
| Ofev | 12 | $129,661 | $10,805 |
| Advair Diskus | 67 | $39,821 | $594 |
| Spiriva | 47 | $23,412 | $498 |
| Symbicort | 66 | $20,789 | $315 |
| Atrovent Hfa | 41 | $17,883 | $436 |
| Flovent Hfa | 28 | $13,774 | $492 |
| Incruse Ellipta | 31 | $11,609 | $374 |
| Breo Ellipta | 28 | $9,791 | $350 |
| Combivent Respimat | 16 | $6,060 | $379 |
| Wixela Inhub | 14 | $5,579 | $399 |
| Anoro Ellipta | 12 | $5,386 | $449 |
| Albuterol Sulfate Hfa | 44 | $2,141 | $49 |
| Ventolin Hfa | 20 | $1,102 | $55 |
| Fluticasone Propionate | 61 | $735 | $12 |
| Azelastine | 15 | $665 | $44 |
| Montelukast | 39 | $439 | $11 |
| Prednisone | 30 | $201 | $7 |
| Pantoprazole | 11 | $166 | $15 |
2020: 15 drugs
| Spiriva | 76 | $40,609 | $534 |
| Advair Diskus | 75 | $39,506 | $527 |
| Symbicort | 85 | $25,256 | $297 |
| Incruse Ellipta | 57 | $20,335 | $357 |
| Combivent Respimat | 36 | $17,039 | $473 |
| Flovent Hfa | 29 | $11,375 | $392 |
| Atrovent Hfa | 25 | $10,380 | $415 |
| Breo Ellipta | 30 | $9,935 | $331 |
| Spiriva Respimat | 11 | $5,062 | $460 |
| Ventolin Hfa | 48 | $2,839 | $59 |
| Albuterol Sulfate Hfa | 23 | $1,151 | $50 |
| Fluticasone Propionate | 40 | $491 | $12 |
| Azithromycin | 16 | $374 | $23 |
| Montelukast | 31 | $268 | $9 |
| Prednisone | 28 | $178 | $6 |
2019: 18 drugs
| Spiriva | 91 | $46,808 | $514 |
| Advair Diskus | 81 | $39,935 | $493 |
| Symbicort | 106 | $37,577 | $355 |
| Incruse Ellipta | 47 | $15,822 | $337 |
| Flovent Hfa | 26 | $9,745 | $375 |
| Combivent Respimat | 18 | $8,923 | $496 |
| Dulera | 27 | $8,177 | $303 |
| Advair Hfa | 16 | $7,463 | $466 |
| Atrovent Hfa | 18 | $6,950 | $386 |
| Ventolin Hfa | 56 | $3,429 | $61 |
| Proair Hfa | 25 | $1,118 | $45 |
| Albuterol Sulfate Hfa | 23 | $920 | $40 |
| Fluticasone Propionate | 52 | $613 | $12 |
| Azelastine | 16 | $559 | $35 |
| Azithromycin | 27 | $471 | $17 |
| Pantoprazole | 17 | $131 | $8 |
| Prednisone | 22 | $125 | $6 |
| Montelukast | 15 | $99 | $7 |
2018: 18 drugs
| Ofev | 13 | $116,664 | $8,974 |
| Advair Diskus | 88 | $53,178 | $604 |
| Spiriva | 69 | $30,816 | $447 |
| Symbicort | 65 | $25,329 | $390 |
| Incruse Ellipta | 50 | $16,446 | $329 |
| Flovent Hfa | 38 | $11,847 | $312 |
| Dulera | 32 | $9,736 | $304 |
| Advair Hfa | 13 | $6,965 | $536 |
| Atrovent Hfa | 19 | $6,750 | $355 |
| Ventolin Hfa | 86 | $5,109 | $59 |
| Qvar Redihaler | 13 | $5,012 | $386 |
| Proair Hfa | 37 | $2,278 | $62 |
| Azelastine | 15 | $943 | $63 |
| Fluticasone Propionate | 73 | $847 | $12 |
| Azithromycin | 28 | $324 | $12 |
| Prednisone | 33 | $284 | $9 |
| Montelukast | 14 | $154 | $11 |
| Trazodone | 11 | $49 | $4 |
2017: 20 drugs
| Advair Diskus | 114 | $53,155 | $466 |
| Spiriva | 91 | $38,203 | $420 |
| Symbicort | 53 | $19,591 | $370 |
| Dulera | 43 | $12,224 | $284 |
| Incruse Ellipta | 29 | $10,911 | $376 |
| Flovent Hfa | 33 | $10,711 | $325 |
| Atrovent Hfa | 31 | $9,654 | $311 |
| Qvar | 22 | $6,453 | $293 |
| Combivent Respimat | 11 | $4,370 | $397 |
| Ventolin Hfa | 78 | $4,142 | $53 |
| Proair Hfa | 61 | $3,702 | $61 |
| Xopenex Hfa | 30 | $2,057 | $69 |
| Azelastine | 24 | $976 | $41 |
| Fluticasone Propionate | 80 | $896 | $11 |
| Montelukast | 40 | $631 | $16 |
| Prednisone | 55 | $422 | $8 |
| Diltiazem | 16 | $223 | $14 |
| Azithromycin | 28 | $179 | $6 |
| Trazodone | 23 | $94 | $4 |
| Omeprazole | 12 | $81 | $7 |
2016: 21 drugs
| Advair Diskus | 78 | $34,294 | $440 |
| Spiriva | 60 | $22,486 | $375 |
| Symbicort | 45 | $12,245 | $272 |
| Atrovent Hfa | 34 | $10,134 | $298 |
| Incruse Ellipta | 29 | $9,543 | $329 |
| Sildenafil | 13 | $6,830 | $525 |
| Qvar | 32 | $6,424 | $201 |
| Dulera | 17 | $4,654 | $274 |
| Ventolin Hfa | 64 | $3,525 | $55 |
| Flovent Hfa | 14 | $3,265 | $233 |
| Proair Hfa | 55 | $2,922 | $53 |
| Xopenex Hfa | 14 | $1,078 | $77 |
| Fluticasone Propionate | 96 | $901 | $9 |
| Azelastine | 18 | $692 | $38 |
| Prednisone | 45 | $381 | $8 |
| Montelukast | 23 | $376 | $16 |
| Azithromycin | 23 | $215 | $9 |
| Omeprazole | 22 | $134 | $6 |
| Atorvastatin | 12 | $133 | $11 |
| Pantoprazole | 11 | $81 | $7 |
| Trazodone | 15 | $50 | $3 |
2015: 17 drugs
| Spiriva | 90 | $31,485 | $350 |
| Advair Diskus | 70 | $27,703 | $396 |
| Symbicort | 53 | $13,759 | $260 |
| Qvar | 39 | $7,362 | $189 |
| Atrovent Hfa | 17 | $4,469 | $263 |
| Combivent Respimat | 13 | $3,864 | $297 |
| Proair Hfa | 35 | $1,890 | $54 |
| Ventolin Hfa | 22 | $1,032 | $47 |
| Fluticasone Propionate | 41 | $582 | $14 |
| Azelastine | 13 | $480 | $37 |
| Amoxicillin-Clavulanate Potass | 11 | $411 | $37 |
| Montelukast | 12 | $269 | $22 |
| Azithromycin | 26 | $223 | $9 |
| Prednisone | 24 | $141 | $6 |
| Omeprazole | 19 | $123 | $6 |
| Metoprolol | 11 | $59 | $5 |
| Amlodipine Besylate | 12 | $44 | $4 |
2014: 14 drugs
| Spiriva | 82 | $27,727 | $338 |
| Advair Diskus | 53 | $19,983 | $377 |
| Symbicort | 42 | $8,748 | $208 |
| Combivent Respimat | 14 | $5,174 | $370 |
| Atrovent Hfa | 13 | $3,111 | $239 |
| Qvar | 17 | $2,887 | $170 |
| Proair Hfa | 50 | $2,576 | $52 |
| Ventolin Hfa | 22 | $976 | $44 |
| Fluticasone Propionate | 28 | $453 | $16 |
| Amox Tr-Potassium Clavulanate | 14 | $235 | $17 |
| Azithromycin | 22 | $147 | $7 |
| Prednisone | 23 | $147 | $6 |
| Omeprazole | 12 | $101 | $8 |
| Ciprofloxacin | 12 | $71 | $6 |
2013: 13 drugs
| Spiriva | 86 | $34,753 | $404 |
| Advair Diskus | 59 | $24,445 | $414 |
| Symbicort | 18 | $5,677 | $315 |
| Proair Hfa | 48 | $3,585 | $75 |
| Atrovent Hfa | 14 | $2,834 | $202 |
| Qvar | 12 | $2,549 | $212 |
| Montelukast | 22 | $1,194 | $54 |
| Ventolin Hfa | 18 | $1,001 | $56 |
| Fluticasone Propionate | 30 | $951 | $32 |
| Azithromycin | 13 | $129 | $10 |
| Prednisone | 13 | $61 | $5 |
| Furosemide | 12 | $42 | $4 |
| Atenolol | 11 | $39 | $4 |
Money from drug and device companies
$22 in 2025
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1396859351
- Licence
- CA A54233California A54233: Current · expires 2026-12-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A542330
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Internal medicine (207R00000X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 12470 De Sanka Ave, Saratoga, CA, 95070
- NPI first listed
- 2006-08-18
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.